CHA
GILD icon

Cedar Hill Associates’s Gilead Sciences GILD Stock Holding History

Cedar Hill Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,331
Closed -$269K – 152
2017
Q3 		$269K Buy
+3,331
New +$255K 0.05% 131
2016
Q2 		– Sell
-35,783
Closed -$3.29M – 76
2016
Q1 		$3.29M Buy
35,783
+930
+3% +$83.9K 0.57% 49
2015
Q4 		$3.53M Sell
34,853
-820
-2% -$85.3K 0.62% 49
2015
Q3 		$3.5M Sell
35,673
-32,563
-48% -$3.62M 0.62% 48
2015
Q2 		$7.99M Sell
68,236
-1,000
-1% -$109K 1.26% 37
2015
Q1 		$6.79M Buy
69,236
+2,335
+3% +$237K 1.08% 46
2014
Q4 		$6.31M Buy
66,901
+2,686
+4% +$278K 1% 49
2014
Q3 		$6.84M Sell
64,215
-2,839
-4% -$278K 1.11% 46
2014
Q2 		$5.56M Sell
67,054
-52,325
-44% -$4.07M 0.88% 49
2014
Q1 		$8.46M Sell
119,379
-6,475
-5% -$508K 1.42% 36
2013
Q4 		$9.45M Sell
125,854
-1,252
-1% -$87.2K 1.68% 24
2013
Q3 		$7.99M Sell
127,106
-6,277
-5% -$375K 1.52% 31
2013
Q2 		$6.84M Buy
+133,383
New +$6.95M 1.34% 31

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cedar Hill Associates's GILD Position: Q4 2017 in Review

Cedar Hill Associates sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 3,331 shares — an estimated $269K sold.

Cedar Hill Associates first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $9.45M in Q4 2013. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Cedar Hill Associates reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Cedar Hill Associates sold 3,331 Gilead Sciences shares in Q4 2017, an estimated $269K.
  • Cedar Hill Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • Cedar Hill Associates's Gilead Sciences position peaked at $9.45M in Q4 2013.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Cedar Hill Associates's 13F filing for Q4 2017, filed 21 Feb 2018.